FDA calendar · April 2018 · built from SEC filings

PDUFA dates April 2018: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in April 2018. The FDA calendar also recorded 1 other catalyst that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in April 2018

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

April 2018: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
April 20, 2018Trazimera (trastuzumab-qyyp)PFEComplete Response Letter—CRL issuedFDA Complete Response Letters

April 2018: dated readouts

No events in this view.

Not submitted to search engines: Fewer than 3 sourced events in the month.

Questions

What PDUFA dates are in April 2018?

0 PDUFA dates fell in April 2018. The FDA calendar also recorded 1 other catalyst that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.